Duchenne News Tags: Wave Life Sciences

April 5, 2023
Wave Life Sciences announces financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.
December 20, 2022
Wave Life Sciences announces positive update from Phase 1b/2a study of WVE-N531 in Duchenne

Experience the magic of camp promise

Complete applications due April 3, 2023.